These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22193624)

  • 1. Functional polymorphisms in promoter survivin gene and its association with susceptibility to bladder cancer in North Indian cohort.
    Jaiswal PK; Goel A; Mandhani A; Mittal RD
    Mol Biol Rep; 2012 May; 39(5):5615-21. PubMed ID: 22193624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of p53 codon 248 (exon7) with urinary bladder cancer risk in the North Indian population.
    Jaiswal PK; Goel A; Mittal RD
    Biosci Trends; 2011; 5(5):205-10. PubMed ID: 22101376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of IL-12, IL-18 variants and serum IL-18 with bladder cancer susceptibility in North Indian population.
    Jaiswal PK; Singh V; Srivastava P; Mittal RD
    Gene; 2013 Apr; 519(1):128-34. PubMed ID: 23403235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspase 9 and caspase 8 gene polymorphisms and susceptibility to bladder cancer in north Indian population.
    Gangwar R; Mandhani A; Mittal RD
    Ann Surg Oncol; 2009 Jul; 16(7):2028-34. PubMed ID: 19412632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of single nucleotide polymorphisms in promoter of matrix metalloproteinase-2, 8 genes with bladder cancer risk in Northern India.
    Srivastava P; Kapoor R; Mittal RD
    Urol Oncol; 2013 Feb; 31(2):247-54. PubMed ID: 21784671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of inflammatory chemokine gene CCL2I/D with bladder cancer risk in North Indian population.
    Singh V; Srivastava P; Srivastava N; Kapoor R; Mittal RD
    Mol Biol Rep; 2012 Oct; 39(10):9827-34. PubMed ID: 22733495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic T lymphocyte antigen 4 (CTLA4) gene polymorphism with bladder cancer risk in North Indian population.
    Jaiswal PK; Singh V; Mittal RD
    Mol Biol Rep; 2014 Feb; 41(2):799-807. PubMed ID: 24390231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two survivin polymorphisms are cooperatively associated with bladder cancer susceptibility.
    Kawata N; Tsuchiya N; Horikawa Y; Inoue T; Tsuruta H; Maita S; Satoh S; Mitobe Y; Narita S; Habuchi T
    Int J Cancer; 2011 Oct; 129(8):1872-80. PubMed ID: 21154810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replicative study of GWAS TP63C/T, TERTC/T, and SLC14A1C/T with susceptibility to bladder cancer in North Indians.
    Singh V; Jaiswal PK; Mittal RD
    Urol Oncol; 2014 Nov; 32(8):1209-14. PubMed ID: 25218484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the Functional Polymorphism of Survivin Gene (-31G/C) and Risk of Breast Cancer in a North Indian Population.
    Rasool I; Afroze D; Wani KA; Yousuf A; Bhat IA; Rah B; Nazir SU; Hussain S; Dubey S
    Clin Breast Cancer; 2018 Aug; 18(4):e671-e676. PubMed ID: 29233639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of single nucleotide polymorphisms in vascular endothelial growth factor gene with bladder cancer risk.
    Jaiswal PK; Tripathi N; Shukla A; Mittal RD
    Med Oncol; 2013 Jun; 30(2):509. PubMed ID: 23430447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Base excision repair pathway genes polymorphism in prostate and bladder cancer risk in North Indian population.
    Mittal RD; Mandal RK; Gangwar R
    Mech Ageing Dev; 2012 Apr; 133(4):127-32. PubMed ID: 22019847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional promoter -31G/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case control study.
    Chen J; Cui X; Zhou H; Qin C; Cao Q; Ju X; Li P; Cai H; Zhu J; Meng X; Wang M; Zhang Z; Shao P; Li J; Yin C
    BMC Cancer; 2013 Jul; 13():356. PubMed ID: 23883402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional promoter -31G>C variant in survivin gene is associated with risk and progression of renal cell cancer in a Chinese population.
    Qin C; Cao Q; Li P; Ju X; Wang M; Chen J; Wu Y; Meng X; Zhu J; Zhang Z; Lu Q; Yin C
    PLoS One; 2012; 7(1):e28829. PubMed ID: 22295057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of survivin re-expression in the development and progression of non-small cell lung cancer.
    Javid J; Mir R; Julka PK; Ray PC; Saxena A
    Tumour Biol; 2015 Jul; 36(7):5543-50. PubMed ID: 25677909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BIRC5 promoter SNPs do not affect nuclear survivin expression and survival of malignant pleural mesothelioma patients.
    Hmeljak J; Erčulj N; Dolžan V; Kern I; Cör A
    J Cancer Res Clin Oncol; 2011 Nov; 137(11):1641-51. PubMed ID: 21861135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between survivin genetic polymorphisms and lung cancer susceptibility.
    Guo G; Zhang Q; Yu Z; Li J; Ding Z; Li J; Tan W
    Int J Clin Exp Pathol; 2015; 8(6):7426-30. PubMed ID: 26261647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of chemokines CCR5∆32, CXCL12G801A, and CXCR2C1208T on bladder cancer susceptibility in north Indian population.
    Singh V; Jaiswal PK; Kapoor R; Kapoor R; Mittal RD
    Tumour Biol; 2014 May; 35(5):4765-72. PubMed ID: 24430363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional polymorphisms in the IL6 gene promoter and the risk of urinary bladder cancer in India.
    Gautam KA; Muktanand T; Sankhwar SN; Goel A; Sankhwar PL; Rajender S
    Cytokine; 2016 Jan; 77():152-6. PubMed ID: 26605964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survivin -31G/C promoter polymorphism and sporadic colorectal cancer.
    Gazouli M; Tzanakis N; Rallis G; Theodoropoulos G; Papaconstantinou I; Kostakis A; Anagnou NP; Nikiteas N
    Int J Colorectal Dis; 2009 Feb; 24(2):145-50. PubMed ID: 18946675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.